Published in Anaerobe on April 16, 2016
Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis (2011) 24.75
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol (2001) 9.62
Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol Microbiol (1999) 2.99
Structure and function of claudins. Biochim Biophys Acta (2007) 2.98
Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J Cell Biol (1997) 2.25
Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot (2012) 2.13
Claudins and the modulation of tight junction permeability. Physiol Rev (2013) 2.05
Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli. Infect Immun (1993) 2.05
Predicted expansion of the claudin multigene family. FEBS Lett (2011) 1.91
Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem (1997) 1.91
Molecular basis of the core structure of tight junctions. Cold Spring Harb Perspect Biol (2010) 1.87
Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model. Mol Microbiol (2008) 1.78
Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology (2001) 1.75
Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett (2000) 1.69
Tight junctions. Structural insight into tight junction disassembly by Clostridium perfringens enterotoxin. Science (2015) 1.62
In Vivo Effects of Clostridium perfringens Enteropathogenic Factors on the Rat Ileum. Infect Immun (1974) 1.59
Evidence that an approximately 50-kDa mammalian plasma membrane protein with receptor-like properties mediates the amphiphilicity of specifically bound Clostridium perfringens enterotoxin. J Biol Chem (1994) 1.43
Crystal structure of a claudin provides insight into the architecture of tight junctions. Science (2014) 1.42
Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region. J Biol Chem (1991) 1.40
Fatal necrotizing colitis following a foodborne outbreak of enterotoxigenic Clostridium perfringens type A infection. Clin Infect Dis (2005) 1.37
Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. J Biol Chem (2007) 1.32
CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin. J Biol Chem (2000) 1.25
Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. Infect Immun (2007) 1.23
Architecture of tight junctions and principles of molecular composition. Semin Cell Dev Biol (2014) 1.21
Isolation and function of a Clostridium perfringens enterotoxin fragment. Infect Immun (1987) 1.19
Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxins. J Biol Chem (2011) 1.18
Compositional and stoichiometric analysis of Clostridium perfringens enterotoxin complexes in Caco-2 cells and claudin 4 fibroblast transfectants. Cell Microbiol (2007) 1.17
Deletion analysis of the Clostridium perfringens enterotoxin. Infect Immun (1997) 1.16
Mapping of functional regions of Clostridium perfringens type A enterotoxin. Infect Immun (1992) 1.14
Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity. J Bacteriol (1989) 1.14
Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3. J Biol Chem (2009) 1.11
The importance of calcium influx, calpain and calmodulin for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin. Cell Microbiol (2005) 1.11
Clostridium perfringens type A enterotoxin induces tissue damage and fluid accumulation in rabbit ileum. J Diarrhoeal Dis Res (1994) 1.08
Claudins in intestines: Distribution and functional significance in health and diseases. Tissue Barriers (2013) 1.07
Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis. Biochem Pharmacol (2008) 1.05
Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis. Infect Immun (1999) 1.05
Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized CaCo-2 cells versus Vero cells. J Biol Chem (2001) 1.04
Role of tyrosine residues in modulation of claudin-4 by the C-terminal fragment of Clostridium perfringens enterotoxin. Biochem Pharmacol (2006) 1.02
Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins. J Mol Biol (2011) 1.02
Fine mapping of the N-terminal cytotoxicity region of Clostridium perfringens enterotoxin by site-directed mutagenesis. Infect Immun (2004) 1.01
Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity. Infect Immun (2008) 0.99
Differential pathways of claudin oligomerization and integration into tight junctions. Tissue Barriers (2013) 0.99
A novel tumor-targeted therapy using a claudin-4-targeting molecule. Mol Pharmacol (2009) 0.98
Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin. Infect Immun (2009) 0.98
Identification of novel Clostridium perfringens type E strains that carry an iota toxin plasmid with a functional enterotoxin gene. PLoS One (2011) 0.97
Use of Clostridium perfringens Enterotoxin and the Enterotoxin Receptor-Binding Domain (C-CPE) for Cancer Treatment: Opportunities and Challenges. J Toxicol (2011) 0.92
Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins. J Biol Chem (2011) 0.92
Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin. MBio (2013) 0.92
Development and application of a mouse intestinal loop model to study the in vivo action of Clostridium perfringens enterotoxin. Infect Immun (2011) 0.91
C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin. Clin Cancer Res (2010) 0.91
On the interaction of Clostridium perfringens enterotoxin with claudins. Toxins (Basel) (2010) 0.90
Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loops. Infect Immun (2014) 0.90
A novel strategy for a drug delivery system using a claudin modulator. Biol Pharm Bull (2006) 0.90
Organization of the cpe locus in CPE-positive clostridium perfringens type C and D isolates. PLoS One (2010) 0.89
Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy. Int J Mol Sci (2013) 0.89
Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins. Toxins (Basel) (2010) 0.88
Cysteine-scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation. Infect Immun (2012) 0.86
Proof of concept for claudin-targeted drug development. Ann N Y Acad Sci (2012) 0.86
Contributions of NanI sialidase to Caco-2 cell adherence by Clostridium perfringens type A and C strains causing human intestinal disease. Infect Immun (2014) 0.85
Assembly and function of claudins: Structure-function relationships based on homology models and crystal structures. Semin Cell Dev Biol (2015) 0.84
Claudin-6: a novel receptor for CPE-mediated cytotoxicity in ovarian cancer. Oncogenesis (2012) 0.83
Chymotrypsin treatment increases the activity of Clostridium perfringens enterotoxin. Toxicon (1991) 0.83
Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer. Int J Cancer (2015) 0.81
Targeting claudin-4 in human pancreatic cancer. Expert Opin Ther Targets (2012) 0.80
Fatal foodborne Clostridium perfringens illness at a state psychiatric hospital--Louisiana, 2010. MMWR Morb Mortal Wkly Rep (2012) 0.80
Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin. Eur J Pharm Sci (2013) 0.80
C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine. PLoS One (2015) 0.78
A synthetic peptide corresponding to the extracellular loop 2 region of claudin-4 protects against Clostridium perfringens enterotoxin in vitro and in vivo. Infect Immun (2014) 0.77
M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine. Vaccine (2014) 0.77
Structure of a C. perfringens enterotoxin mutant in complex with a modified Claudin-2 extracellular loop 2. J Mol Biol (2014) 0.75
Clostridium perfringens type A-E toxin plasmids. Res Microbiol (2014) 0.78